| Literature DB >> 34046605 |
Christopher B Wang1,2, Álvaro Lorente-Macías3, Carrow Wells1,2, Julie E Pickett1,2, Alfredo Picado1,2, William J Zuercher1,2,4, Alison D Axtman1,2.
Abstract
RIOK2 is an understudied kinase associated with a variety of human cancers including non-small cell lung cancer and glioblastoma. No potent, selective, and cell-active chemical probe currently exists for RIOK2. Such a reagent would expedite re-search into the biological functions of RIOK2 and validate it as a therapeutic target. Herein, we describe the synthesis of naphthyl-pyridine based compounds that have improved cellular activity while maintaining selectivity for RIOK2. While our compounds do not represent RIOK2 chemical probes, they are the best available tool molecules to begin to characterize RIOK2 function in vitro. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 34046605 PMCID: PMC8130602 DOI: 10.1039/d0md00292e
Source DB: PubMed Journal: RSC Med Chem ISSN: 2632-8682